Weiwei Zhang
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 13
- Pluripotent Stem Cells Research 7
- Epigenetics and DNA Methylation 7
- Cancer-related gene regulation 6
- CRISPR and Genetic Engineering 5
- DNA Repair Mechanisms 4
- Cancer Research top 10%
- Aging top 10%
- Oncology top 10%
-
- Lymphoma Diagnosis and Treatment 9
-
- Autophagy in Disease and Therapy 5
- Co-authors
- Yuin‐Han LohHuck‐Hui NgXi ChenJoshy GeorgeFeng CongHong JiangBing LimWei Xiao
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Genes & Development (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Weiwei Zhang
95 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 2.1k
- Cancer Research 299
- Aging 29
- Oncology 332
- Biological Psychiatry 28
Countries citing papers authored by Weiwei Zhang
This map shows the geographic impact of Weiwei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Zhang more than expected).
Fields of papers citing papers by Weiwei Zhang
This network shows the impact of papers produced by Weiwei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Zhang. The network helps show where Weiwei Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiwei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 26 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 29 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 5 | |
| 13 | 2020 | 20 | |
| 14 | 2018 | 64 | |
| 15 | 2017 | 17 | |
| 16 | 2017 | 27 | |
| 17 | 2016 | 52 | |
| 18 | 2014 | 30 | |
| 19 | 2011 | 30 | |
| 20 | 2007 | 407 |
About Weiwei Zhang
Weiwei Zhang is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 102 papers that have together received 2.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Lymphoma Diagnosis and Treatment (9 papers), Pluripotent Stem Cells Research (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (6 papers), CRISPR and Genetic Engineering (5 papers), Autophagy in Disease and Therapy (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Molecular Biology (2.1k citations), Cancer Research (299 citations) and Aging (29 citations). Weiwei Zhang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yuin‐Han Loh, Huck‐Hui Ng, Xi Chen, Joshy George, Feng Cong, Hong Jiang, Bing Lim, Wei Xiao, Mariana Yaneva and Bo Feng. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.